Usefulness of Hospital and Community Pharmacists Collaborating to Manage Capecitabine-induced Severe Hand-foot Syndrome in Patients with Breast Cancer

Volume 25, Issue 11, November 2024, Pages 3877-3883

Shinya Takada; Kengo Umehara; Tahatsu Kanae; Yuta Kimura; Fukai Yuta; Shikishima Karin; Mitsugu Yamamoto; Hideki Maeda; Nobumoto Tomioka; Kenichi Watanabe; Hashishita Hirokazu

• View Article
• PDF 483.78 K

A Randomized Single-Blinded Phase II Trial Comparing Efficacy and Quality of Life of Topical Aloe Vera Gel Plus Urea Cream Versus Urea Cream Alone for Prevention of Hand Foot Syndrome in Cancer Patients Receiving Capecitabine

Volume 25, Issue 6, June 2024, Pages 2203-2210

Lucksika Wanichtanom; Gorn Vrakornvoravuti; Metavee Boonsiri; Apisada Suthepwanon

• View Article
• PDF 477.7 K

Association of Cytidine Deaminase Polymorphism with Capecitabine Effectiveness in Breast Cancer Patients

Volume 24, Issue 12, December 2023, Pages 4219-4225

Ali Amal Aldeen Majeed; Ahmed Salih Sahib; Hasanian Shakir Mahmood; Karar Kadhim Mohsin; Raaid Fadhl Abbas

• View Article
• PDF 436.78 K

Could Concurrent Capecitabine with Hypofractionated Radiotherapy in Elderly Patients with Muscle-Invasive Bladder Cancer be an Option?

Volume 23, Issue 5, May 2022, Pages 1733-1740

Ayatallah A Youssief; Doaa A Gamal; M S El-Naggar; Mohamed A Zarzor; Refaat A; Shimaa Ahmed

• View Article
• PDF 545.08 K

The Effects of Phyllanthus niruri Linn on Infiltrating Dendritic Cell and Ratio of Neutrophile/Lymphocytes in Chemotherapy of Sprague-Dawley Rats with Colorectal Cancer

Volume 22, Issue 11, November 2021, Pages 3561-3568

Michael Tendean; Ignatius Riwanto

• View Article
• PDF 671.72 K

Low Incidence of the DPD IVS14+1G>A Polymorphism in Jordanian Breast and Colorectal Cancer patients

Volume 18, Issue 6, June 2017, Pages 1651-1654

Mohammad Al-khateeb; Abdalla Awidi; Kamal Al-Hadidi; Abdelkader Battah

• View Article
• PDF 323.98 K

An Updated Meta-analysis and System Review:is emcitabine+Fluoropyrimidine in Combination a Better herapy Versus Gemcitabine Alone for Advanced and Unresectable Pancreatic Cancer?

Volume 16, Issue 14, December 2015, Pages 5681-5686

• View Article
• PDF 979.15 K

Aromatase Inhibition and Capecitabine Combination as 1st or 2nd Line Treatment for Metastatic Breast Cancer - a Retrospective Analysis

Volume 16, Issue 15, December 2015, Pages 6359-6364

• View Article
• PDF 459.1 K

Capecitabine Pattern of Usage, Rate of Febrile Neutropaenia and Treatment Related Death in Asian Cancer Patients in Clinical Practice

Volume 16, Issue 4, April 2015, Pages 1449-1453

• View Article
• PDF 352.45 K

Second-Line Capecitabine and Oxaliplatin Combination for Gemcitabine-Resistant Advanced Pancreatic Cancer

Volume 15, Issue 17, December 2014, Pages 7119-7123

• View Article
• PDF 586.62 K

Modified Docetaxel and Cisplatin in Combination with Capecitabine (DCX) as a First-Line Treatment in HER2-Negative Advanced Gastric Cancer

Volume 15, Issue 20, December 2014, Pages 8661-8666

• View Article
• PDF 431.84 K

Adherence to Capecitabine Treatment and Contributing Factors among Cancer Patients in Malaysia

Volume 15, Issue 21, December 2014, Pages 9225-9232

• View Article
• PDF 451.1 K

First-Line Mono-Chemotherapy in Frail Elderly Patients with Metastatic Colorectal Cancer

Volume 15, Issue 7, July 2014, Pages 3157-3161

• View Article
• PDF 547 K

Lack of Prognostic Value of Mean Corpuscular Volume with Capecitabine Therapy in Metastatic Breast Cancer

Volume 15, Issue 6, June 2014, Pages 2501-2504

• View Article
• PDF 349.95 K

Efficacy and Tolerability of Adjuvant Oral Capecitabine plus Intravenous Oxaliplatin (XELOX) in Asian Patients with Colorectal Cancer: 4-Year Analysis

Volume 14, Issue 11, November 2013, Pages 6585-6590

• View Article
• PDF 568.69 K

Can Capecitabine be used Instead of Concurrent Bolus 5-FU in Postoperative Chemoradiotherapy for Gastric Adenocarcinoma?

Volume 14, Issue 9, September 2013, Pages 5127-5131

• View Article
• PDF 405.41 K

Xeliri Plus Bevacizumab Compared with Folfiri Plus Bevacizumab as First-Line Setting in Patients with Metastatic Colorectal Cancer: Experiences at Two-Institutions

Volume 14, Issue 4, April 2013, Pages 2283-2288

• View Article
• PDF 416.09 K